SU1022655A3 - Способ получени производных 1,1-бифенил-2-илалкиламина или их солей - Google Patents

Способ получени производных 1,1-бифенил-2-илалкиламина или их солей Download PDF

Info

Publication number
SU1022655A3
SU1022655A3 SU813229052A SU3229052A SU1022655A3 SU 1022655 A3 SU1022655 A3 SU 1022655A3 SU 813229052 A SU813229052 A SU 813229052A SU 3229052 A SU3229052 A SU 3229052A SU 1022655 A3 SU1022655 A3 SU 1022655A3
Authority
SU
USSR - Soviet Union
Prior art keywords
hydrogen
alkyl
salts
ylkylamine
diphenyl
Prior art date
Application number
SU813229052A
Other languages
English (en)
Inventor
Брайант Лейсфилд Вильям
Ли Саймонд Ричард
Original Assignee
Эли Лилли Энд Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани (Фирма) filed Critical Эли Лилли Энд Компани (Фирма)
Application granted granted Critical
Publication of SU1022655A3 publication Critical patent/SU1022655A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Способ получени  производных 1,1-Оифенил-2-илалкиламина общей формулы RI 1Н2- 5Нг-йн-сн2- С он 2 где RI - водород или С -С алкил; R2-C,-C4- алкил, или их солей, отличающийс  тем, что 1,2,-эпокск-4-{1,1-бифенил2-ил )-бутан ввод т во взаимодействие с амином общей формула ,RI НИ; СО где RJ и R2 имеют указанные значени , при нагревании в органическом растворителе , таком как этанол, и выде- S л ют целевой продукт в свободном виде или в виде соли.

Description

лаблени  сердечной аритмии, введение испытываемого соединени  в общем случае продолжали до тех пор, пока собаке не будет введено удвоенное количество этого соединени .по сравнению с тем количеством, кото .рое вызвало первые признаки ослаблени  сердечной аритмий. После того, как введение искомого количества испытываемого соединени  закончено,
сердечную де тельность собаки исследоэали при помощи электрокардиограммы в течение такого времени, чтобы убедитьс , что нормальна  сердечна  де тельность собаки восстановилась окончательно, или в течение 2ч, после чего испытание завер7 шают.
Результаты испытаний приведены в таблице
Ы,К-диметил-80
4-1-(4-фтор) ( -бифенил-2- .85
ил)-бутиламин
Ы,.Ы-ДИИЭОПРОГ1ИЛ-60
2-окси-4-(1,1-55
бифенил.-2-ил)-бу-70
ТИЛёМИИН65
4,0
8,0
12 3,4
83 48 26 23
3,8 4,0 3,0 3,2

Claims (2)

  1. Способ получения производных
    1,1’ -бифенил-2-илалкиламина общей формулы
    Ri <н2-снг-йн-(!н2
    ОН где R; - водород ИЛИ С4-С4алкил;
    Rj~Ct-C4- алкил, или их солей, о т л и ч а ю щ и й с я тем, что 1,2,-эпокси-4-(1,1-бифенил-
  2. 2-ил)-бутан вводят во взаимодействие с амином общей формула
    „.SU» 1022655 где R; и Rj имеют указанные значения, при нагревании в органическом растворителе, таком как этанол, и выделяют целевой продукт в свободном ‘виде или в виде соли.
SU813229052A 1979-03-12 1981-01-14 Способ получени производных 1,1-бифенил-2-илалкиламина или их солей SU1022655A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1953479A 1979-03-12 1979-03-12

Publications (1)

Publication Number Publication Date
SU1022655A3 true SU1022655A3 (ru) 1983-06-07

Family

ID=21793713

Family Applications (2)

Application Number Title Priority Date Filing Date
SU802892804A SU940645A3 (ru) 1979-03-12 1980-03-12 Способ получени производных 1,1 @ -бифенил-2-илалкиламина
SU813229052A SU1022655A3 (ru) 1979-03-12 1981-01-14 Способ получени производных 1,1-бифенил-2-илалкиламина или их солей

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU802892804A SU940645A3 (ru) 1979-03-12 1980-03-12 Способ получени производных 1,1 @ -бифенил-2-илалкиламина

Country Status (31)

Country Link
EP (1) EP0015776B1 (ru)
JP (1) JPS55127347A (ru)
KR (1) KR840000103B1 (ru)
AR (1) AR228852A1 (ru)
AT (1) AT367395B (ru)
AU (1) AU528060B2 (ru)
BE (1) BE882167A (ru)
CA (1) CA1144926A (ru)
CH (1) CH644094A5 (ru)
CS (1) CS215052B2 (ru)
DD (1) DD149664A5 (ru)
DE (1) DE3060611D1 (ru)
DK (1) DK103480A (ru)
ES (6) ES8105262A1 (ru)
FI (1) FI800736A (ru)
FR (1) FR2451363A1 (ru)
GB (1) GB2046256B (ru)
GR (1) GR68036B (ru)
HU (1) HU180334B (ru)
IE (1) IE49552B1 (ru)
IL (1) IL59557A (ru)
IT (1) IT1140773B (ru)
LU (1) LU82237A1 (ru)
MX (1) MX6219E (ru)
NZ (1) NZ193079A (ru)
PH (1) PH14749A (ru)
PL (1) PL121662B1 (ru)
PT (1) PT70928A (ru)
RO (1) RO79906A (ru)
SU (2) SU940645A3 (ru)
ZA (1) ZA801421B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100470454B1 (ko) * 2002-05-14 2005-02-05 대한민국 돼지 사료공급을 위한 자동조절급이기
CA2573109A1 (en) * 2004-06-17 2006-01-26 Thomas A. Dix Non-natural amino acids
ES2742261T3 (es) * 2011-04-15 2020-02-13 Hivih Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos
EP2821104A1 (en) 2013-07-05 2015-01-07 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES236010A1 (es) * 1956-06-29 1957-12-16 Lab Pharmaceutica Dr C Janssen UN PROCEDIMIENTO PARA PREPARAR NUEVOS DERIVADOS PARASIMPATICOLiTICAMENTE ACTIVOS DE ALFAS-DEFENIL PROPANO
US3433836A (en) * 1966-01-14 1969-03-18 Rexall Drug Chemical Alpha-diaryl alpha,omega-alkylene glycol-dilower-alkylamines
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
GB1523655A (en) * 1975-02-10 1978-09-06 Armour Pharma 4-(4-biphenylyl) butylamines and treatment of the animal organism therewith

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Машковский М.Д. Лекарственные средства. Ч 1, Ч., Медицина, 1972, с. 357. 2. Бюлер К., Пирсон Д. Органические синтезы. Ч 1, М., Мир, 1973, с. 529. *

Also Published As

Publication number Publication date
KR830001854A (ko) 1983-05-19
ES497209A0 (es) 1981-12-16
ES497208A0 (es) 1981-12-16
ES8201528A1 (es) 1981-12-16
JPS55127347A (en) 1980-10-02
ES8201527A1 (es) 1981-12-16
ES8201525A1 (es) 1981-12-16
CA1144926A (en) 1983-04-19
ES8201529A1 (es) 1981-12-16
ATA134580A (de) 1981-11-15
DK103480A (da) 1980-09-13
AU5630280A (en) 1980-09-18
EP0015776B1 (en) 1982-06-30
PT70928A (en) 1980-04-01
FR2451363B1 (ru) 1983-01-14
BE882167A (fr) 1980-09-11
MX6219E (es) 1984-12-21
CS215052B2 (en) 1982-07-30
AT367395B (de) 1982-06-25
DE3060611D1 (en) 1982-08-19
PH14749A (en) 1981-11-20
ES489469A0 (es) 1981-05-16
IE800493L (en) 1980-09-12
KR840000103B1 (ko) 1984-02-11
ZA801421B (en) 1981-10-28
ES8201526A1 (es) 1981-12-16
EP0015776A1 (en) 1980-09-17
SU940645A3 (ru) 1982-06-30
ES8105262A1 (es) 1981-05-16
GR68036B (ru) 1981-10-27
AR228852A1 (es) 1983-04-29
IE49552B1 (en) 1985-10-30
FR2451363A1 (fr) 1980-10-10
ES497210A0 (es) 1981-12-16
ES497206A0 (es) 1981-12-16
LU82237A1 (fr) 1980-06-06
DD149664A5 (de) 1981-07-22
NZ193079A (en) 1982-05-31
PL121662B1 (en) 1982-05-31
HU180334B (en) 1983-02-28
FI800736A (fi) 1980-09-13
IL59557A0 (en) 1980-06-30
GB2046256A (en) 1980-11-12
GB2046256B (en) 1983-04-20
IT1140773B (it) 1986-10-10
CH644094A5 (fr) 1984-07-13
IL59557A (en) 1983-10-31
ES497207A0 (es) 1981-12-16
IT8020503A0 (it) 1980-03-11
AU528060B2 (en) 1983-04-14
RO79906A (ro) 1982-10-11
PL222601A1 (ru) 1981-01-30

Similar Documents

Publication Publication Date Title
DE3884563T2 (de) Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel.
US3261859A (en) Basically substituted phenyl acetonitrile compounds
SU1538893A3 (ru) Способ получени гидрохлорида N-деформил-N [N,N -бис(2-хлорэтил)]дистамицина А
DE2705025A1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
SI9300452A (en) Substituted thiazolidinedione derivates
SE436027B (sv) Nya estrar av kvarternera ammoniumsalter med antikolinerg anti-sekretorisk verkan och farmaceutiska kompositioner innehallande dessa salter
US3855285A (en) Acylmethylthio-trifluoromethyl-benzoic acids
SU1022655A3 (ru) Способ получени производных 1,1-бифенил-2-илалкиламина или их солей
US4018830A (en) Phenylthioaralkylamines
RU1776257C (ru) Способ получени ацилоксипропаноламинов
US4055665A (en) Treating arrythmia with phenylthioaralkylamines
JPS60156653A (ja) β−フエネタノ−ルアミン誘導体
DE69007422T2 (de) 1-(4-Aminophenyl)-2-piperidinopropanon-Derivate, Verfahren zu deren Herstellung und therapeutische Verwendung.
CA1186325A (en) Orthoarylideneaminophenethylamines and a method for producing the same
DD298786A5 (de) Thiophene
US4016284A (en) Derivatives of 1,3-benzodioxole, the preparation and use thereof
KR810001320B1 (ko) 신규한 이소부티라미드류의 제조방법
CH356121A (de) Verfahren zur Herstellung von N-monosubstituierten Amiden vona-Aminoalkyl-a-phenyl-essigsäuren
EP0011092A1 (de) Alpha-Aminophenylessigsäurederivate zur Verwendung bei der Behandlung von Entzündungen sowie neue alpha-Aminophenylessigsäurederivate
DE2146676A1 (de) Cyclopropano- eckige Klammer auf b eckige Klammer zu -tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung
KR810001697B1 (ko) 이소부티라미드 유도체의 신규한 제조방법
DE2310572A1 (de) Substituierte o-mercaptobenzamide und disulfide
SU522597A1 (ru) Бис-(диалкиламиноалкиламиды) @ -труксилловой кислоты, про вл ющие курареподобную активность
EP0334147A1 (de) Disubstituierte Pyrrole
DE69211773T2 (de) Amidderivate von 1-Amino-Octahydropyrido[2,1-c][1,4]oxazin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen